執(zhí)照.jpg)
二氫丹參酮I
分析標(biāo)準(zhǔn)品,HPLC≥98%
Dihydrotanshinone I
CAS號：87205-99-0
分子式：C18H14O3
分子量：278.3
MDL：MFCD28016070
貨號 | 規(guī)格/參數(shù)/品牌 | 價格 | 貨期 |
YJ-B20357-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥600.00 | 現(xiàn)貨 |
YJ-B20357-200mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2500.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：214.0 to 218.0 ℃
沸點(diǎn)：479.2 ℃ at 760 mmHg
外觀：紅褐色針狀結(jié)晶
溶解性：DMSO：1mg/ml
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(44篇)
44. [IF=5.6] Ruoxin Tu et al."The CCR5/ROS/NRF2 axis Mediates Dihydrotanshinone I-Induced oxidative stress and apoptosis in hepatocellular carcinoma."BIOCHEMICAL PHARMACOLOGY.2025 Jul;:117119
43. [IF=3.4] Wang Qiaona et al."Anti-oxidative effect of Salvia miltiorrhiza Bunge fermented with Shiraia bambusicola Henn. against H2O2-induced injury in PC12 cells."BMC Complementary Medicine and Therapies.2025 Dec;25(1):1-13
42. [IF=4] Lijuan Wu et al."Integration of chromatographic fractionation, quantitative 1H-NMR and serially coupled achiral-chiral LC–MS/MS enables multi-components-targeted determination of Salvia miltiorrhiza in an authentic compound-independent manner."JOURNAL OF
41. [IF=4.9] Kewei Zuo et al."Transcriptome- and Metabolome-Based Regulation of Growth, Development, and Bioactive Compounds in Salvia miltiorrhiza (Lamiaceae) Seedlings by Different Phosphorus Levels."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Jan;26(13):6253
40. [IF=8.3] Bing Han et al."Dihydrotanshinone I inhibits ovarian tumor growth by suppressing ITGB1/FAK-mediated extracellular matrix signaling."PHYTOMEDICINE.2025 Jun;:157023
39. [IF=11.6] Chengtao Sun et al."Dihydrotanshinone I Induces Autophagic Cell Death in Ovarian Cancer by Disrupting the SORT1-Mediated Autophagy–Lysosome Pathway."Engineering.2025 Jun;:
38. [IF=24.9] Jie Zhang et al."Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47."Cancer Communications.2025 Jun 10
37. [IF=4.8] Xiaoyan Peng et al."Phytochemical Analysis and Neuroprotective Effect of Salvia castanea Diels f. Tomentosa Stib Extracts."Pharmaceuticals.2025 May;18(5):728
36. [IF=5.7] Xue-Zhang et al."Discovery of Tetrahydro Tanshinone I as a Naturally Occurring Covalent Pan-Inhibitor Against Gut Microbial Bile Salt Hydrolases."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2024;XXXX(XXX):XXX-XXX
35. [IF=8.3] Ruiyan Zhu et al."Abscisic acid enhances SmAPK1-mediated phosphorylation of SmbZIP4 to positively regulate tanshinone biosynthesis in Salvia miltiorrhiza."NEW PHYTOLOGIST.2024 Nov;:
34. [IF=4.9] Zhongda Cao et al."Baicalin Inhibits FIPV Infection In Vitro by Modulating the PI3K-AKT Pathway and Apoptosis Pathway."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2024 Jan;25(18):9930
33. [IF=8.3] Cheng Jiang et al."A Supramolecular Antibiotic Targeting Drug-Resistant Pseudomonas aeruginosa through the Inhibition of Virulence Factors and Activation of Acquired Immunity."ACS Applied Materials & Interfaces.2024;16(32):41828–41842
32. [IF=3.1] Miao Wang et al."Tanshinone IIA, originated from Salvia miltiorrhiza, activated EPO/EPOR-JAK2-STAT5 pathway in rat blood deficiency therapy."SOUTH AFRICAN JOURNAL OF BOTANY".2024 Jul;170:105
31. [IF=7.9] Yunmeng Nie et al."Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma."PHYTOMEDICINE".2024 Jul;130:155767
30. [IF=9.5] Ruya Wang et al."Molecularly Imprinted Heterostructure-Assisted Laser Desorption Ionization Mass Spectrometry Analysis and Imaging of Quinolones."ACS Applied Materials & Interfaces".2024;XXXX(XXX):XXX-XXX
29. [IF=4.6] Yun Zhang et al."G-Quadruplexes Formation by the C9orf72 Nucleotide Repeat Expansion d(GGGGCC)n and Conformation Regulation by Fangchinoline."MOLECULES.2023 Jan;28(12):4671
28. [IF=4.271] Yue Li et al."15,16-dihydrotanshinone I in Danshen ethanol extract aggravated cholestasis by inhibiting Cyp3a11 mediated bile acids hydroxylation."TOXICOLOGY LETTERS.2023 Mar;377:62
27. [IF=6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396
26. [IF=6.208] Huan Zhao et al."Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(23):15180
25. [IF=6.317] Ping Huang et al."Optimization of smashing tissue and ultrasonic extraction of tanshinones and their neuroprotective effect on cerebral ischemia/reperfusion injury by inhibiting parthanatos."Food & Function.2022 Aug;:
24. [IF=7.376] Chengtao Sun et al."Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation."Free Radical Bio Med. 2022 Feb;180:220
23. [IF=3.411] Liu Hongyan et al."Effect Study of Continuous Monoculture on the Quality of Salvia miltiorrhiza Bge Roots."Biomed Res Int. 2020;2020:4284385
22. [IF=4.411] Yuanyuan Li et al."Quantitative Determination and Validation of Four Ketones in Salvia miltiorrhiza Bunge Using Quantitative Proton Nuclear Magnetic Resonance Spectroscopy."Molecules. 2020 Jan;25(9):2043
21. [IF=7.514] Tong Wang et al."A hydrophobic deep eutectic solvents-based integrated method for efficient and green extraction and recovery of natural products from Rosmarinus officinalis leaves, Ginkgo biloba leaves and Salvia miltiorrhiza roots."Food Chem. 2021 Nov;3
20. [IF=7.514] Tiehua Zhang et al."In vitro and in silico perspectives on estrogenicity of tanshinones from Salvia miltiorrhiza."Food Chem. 2019 Jan;270:281
19. 崔偉亮. 丹參酒炙前后HPLC指紋圖譜色譜峰歸屬比較[J]. 遼寧中醫(yī)雜志, v.46;No.507(08):1707-1709.
18. 王蕓, 陳軍峰, 張磊,等. 基于"有效成分-性狀"的關(guān)聯(lián)分析評價丹參品質(zhì)的研究[J]. 世界科學(xué)技術(shù):中醫(yī)藥現(xiàn)代化, 2019(5):835-843.
17. 敏敏 趙志國 劉偉 等. HPLC-DAD法同時測定三種來源丹參飲片中水溶性和脂溶性成分[J]. 山東科學(xué) 2019(6).
16. 尉廣飛 劉謙 李佳 等. 丹參根部活性成分分布規(guī)律研究[J]. 山東科學(xué) 2015 28(05):7-13.
15. 梁從蓮 張永清 李佳 等. 不同株系丹參有效成分比較研究[J]. 山東科學(xué) 2018(4):31-38.
14. 張玉, 戚瑩雪, 王蕾,等. 山東丹參脂溶性成分的地域分布特點(diǎn)研究[J]. 中藥材, 2018, 041(011):2522-2526.
13. 張芮乾,吳曉毅,胡添源,宋雅迪,高偉,黃璐琦.基于丹參酮類化合物生源途徑的丹參質(zhì)量標(biāo)志物研究思路探討[J].中國中藥雜志,2020,45(13):3098-3103.
12. 崔偉亮 李慧芬 張學(xué)蘭 等. UPLC-QE/MS法分析丹參酒炙前后5種質(zhì)變化合物[J]. 中成藥 2019 041(004):844-849.
11. 程沛, 韓東岐, 胡偉慧,等. 高效液相色譜法同時測定丹參中10種水溶性和4種脂溶性成分的含量[J]. 藥物分析雜志, 2015(06):991-996.
10. 馮思念 王瑞 顧雯 等. 不同強(qiáng)度的紅藍(lán)光質(zhì)對丹參根系形態(tài)和有效成分積累的影響[J]. 中草藥 2019(21).
9. 胡偉慧 韓東岐 江坤 等. RP-HPLC法同時測定甘西鼠尾**草中12種成分的含量[J]. 藥物分析雜志 2016 v.36(03):486-493.
8. 程汝濱 樓招歡 葛宇清 等. 二氫丹參酮調(diào)控胃癌細(xì)胞增殖、遷移和凋亡的作用和機(jī)制探討[J]. 中華中醫(yī)藥雜志 2017 032(007):2936-2941.
7. 程協(xié)枝 黃斐超 陳江田. 二氫丹參酮調(diào)控Wnt/β-catenin信號通路抑制大腸癌細(xì)胞增殖的研究[J]. 中國臨床藥理學(xué)雜志 2019(15).
6. 倪建華 朱江波 殷國林 等. 二氫丹參酮經(jīng)GSK3β/Wnt途徑調(diào)節(jié)膀胱癌T-24細(xì)胞增殖及侵襲的機(jī)制研究[J]. 中國藥師 2020(7):1256-1260.
5. 葛宇清 程汝濱 陳夢 等. 二氫丹參酮抑制人胃癌SGC7901細(xì)胞侵襲遷移作用及機(jī)制研究[J]. 中草藥 2017 48(015):3138-3144.
4. 陳亮 董長城. 二氫丹參酮對人非霍奇金淋巴瘤Raji細(xì)胞增殖 凋亡的影響及機(jī)制[J]. 世界中醫(yī)藥 2019 v.14(12):119-122.
3. 鐘廣俊 王兆軍 王道榮 等. 二氫丹參酮對人胃癌細(xì)胞MKN-45增殖和凋亡的影響研究[J]. 中國臨床藥理學(xué)雜志 2019 035(022):2872-2874.
2. 孫蓓 葉因濤 王冬 錢鈞強(qiáng) 婁建石.二氫丹參酮對人肺癌GLC-82細(xì)胞的抑制作用及其機(jī)制研究[J].中國藥房 2015 26(34):4775-4778.
1. 李慧芬 宋夢晗 崔偉亮 等. 一測多評法測定丹參酒炙前后4種丹參酮類成分的含量[J]. 山東中醫(yī)雜志 2018 037(005):416-419 428.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤色十余年，是客戶您值得信賴的科研合作伙伴!
如果您受時間、試驗(yàn)條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
